Society guideline links: Treatment and prevention of seasonal influenza with antivirals

Introduction —

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Seasonal influenza vaccination".)

Canada

●Canadian Paediatric Society (CPS): Practice point on the use of antiviral drugs for influenza – Guidance for practitioners (2018, reaffirmed 2024)

●Association of Medical Microbiology and Infectious Disease (AMMI) Canada: Influenza – Management and emerging issues, update (2023)

●AMMI Canada: Use of antiviral drugs for seasonal influenza – Foundation document for practitioners, update (2019)

United States

●Centers for Disease Control and Prevention (CDC): Influenza (flu) – For health care providers

•Influenza antiviral medications – Summary for clinicians

•Recommendations for obstetric health care providers related to use of antiviral medications in the treatment and prevention of influenza

●American Academy of Pediatrics (AAP): Policy statement on recommendations for prevention and control of influenza in children, 2024-2025 (2024)

•AAP: Technical report on recommendations for prevention and control of influenza in children, 2024-2025 (2024)

●AAP: Red Book – Influenza (2024)